Novavax announced Tuesday its potential vaccine to prevent Covid-19 generated a promising immune response in an early-stage clinical trial, but the biotech company’s stock fell on concerns about its … [+3470 chars]
Novavax shares fall as much as 32% after releasing early trial data on coronavirus vaccine – CNBC
